期刊文献+

SOX5和PrPc在口腔鳞状细胞癌中的表达及临床意义 被引量:4

Expression and significance of SOX5 and PrPc in OSCC
暂未订购
导出
摘要 目的:研究口腔鳞状细胞癌(OSCC)组织中,性别决定区Y框蛋白5(SOX5)及细胞型朊病毒蛋白(PrPc)的表达和临床意义。方法:采用免疫组化法检测94例OSCC组织芯片及30例癌旁组织芯片中SOX5及PrPc的表达情况。结果:OSCC组织中SOX5和PrPc表达阳性率分别为69.15%和68.09%,明显高于癌旁组织中的表达(30.00%和20.00%)(P<0.05)。SOX5的表达与淋巴结转移相关(P<0.05),与性别、年龄、浸润深度、TNM分期、分化程度无关(P>0.05);PrPc的表达与肿瘤分化程度、患者年龄相关(P<0.05),与性别、浸润深度、TNM分期、淋巴结转移无关(P>0.05)。SOX5与PrPc的表达呈正相关(r=0.432,P<0.01)。结论:SOX5和PrPc有可能作为OSCC早期诊断的生物标志物。 Objective: To investigate the expression of sex determining reion Y-box 5(SOX5) and cellular prion protein(PrPc) in oral squamous cell carcinoma(OSCC) and its clinical significance. Methods: Immunohistochemistry was performed to detect SOX5 and PrPc levels in tissue microarrays containing 94 OSCC specimens and 30 paracancerous(PC) specimens respectively. Results: The positive rates of SOX5 and PrPc in OSCC were higher than those in PC(69.15% and 68.09% vs 30.00% and 20.00%,P<0.05 respectively). The expression level of SOX5 was correlated with the metastasis(P<0.05), that of PrPc was correlated with the patient age and differentiation of OSCC(P<0.05). The expression of SOX5 was positively correlated with the expression levels of PrPc(r=0.432, P<0.01). Conclusion: SOX5 and PrPc may serve as biomarkers for early diagnosis of OSCC.
作者 王可楹 郑军 刘佳瑞 赵娟 徐江 曾妍 WANG Keying;ZHENG Jun;LIU Jiarui;ZHAO Juan;XU Jiang;ZENG Yan(Key La-boratory of Xinjiang Endemic and Ethnic Disease,China,Shihezi 832000;Department of Stomatology,The First Affiliated Hospi-tal,School of Medicine,Shihezi University)
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2020年第4期601-604,共4页 Journal of Practical Stomatology
基金 国家自然科学基金(编号:81560473,81560442) 石河子大学国际合作项目(编号:GJHZ201901)。
关键词 口腔鳞状细胞癌(OSCC) 性别决定区Y框蛋白5(SOX5) 细胞型朊病毒蛋白(PrPc) Oral squamous cell carcinoma(OSCC) Sex determining reion Y-box 5(SOX5) Cellular prion protein(PrPc)
  • 相关文献

参考文献6

二级参考文献25

  • 1Miyahara M,Tanuma J,Sugihara K. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma[J].Cancer,2007,(06):1287-1294.doi:10.1002/cncr.22900.
  • 2Argiris A,Karamouzis MV,Raben D. Head and neck cancer[J].The Lancet,2008,(9625):1695-1709.
  • 3Sano D,Myers JN. Metastasis of squamous cell carcinoma of the oral tongue[J].Cancer and Metastasis Review,2007,(3/4):645-662.
  • 4Mehrpour M,Codogno P. Prion protein:from physiology to cancer biology[J].Cancer Letters,2010,(01):1-23.
  • 5Fischer MB,Roeckl C,Parizek P. Binding of diseaseassociated prion protein to plasminogen[J].Nature,2000,(6811):479-483.
  • 6Liang J,Pan YL,Ning XX. Overexpression of PrPC and its antiapoptosis function in gastric cancer[J].Tumour Biology,2006,(02):84-91.
  • 7Wang JH,Du JP,Li SJ. Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells[J].J Dig Dis,2012,(03):143-152.
  • 8de Wit M,Jimenez CR,Carvalho B. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression[J].Gut,2012,(06):855-864.
  • 9Li C,Yu S,Nakamura F. Binding of pro-pfion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer[J].Journal of Clinical Investigation,2009,(09):2725-2736.
  • 10Meslin F,Conforti R,Mazouni C. Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer[J].Annals of Oncology,2007,(11):1793-1798.

共引文献27

同被引文献49

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部